PRESS RELEASE published on 04/24/2025 at 17:45, 1 year 2 months ago 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical announces major milestones in its 2024 full-year results including transformative agreements, regulatory validations, and clinical advancements, positioning the company for market launch Medical Technology Affluent Medical Clinical Advancements Market Launch 2024 Full-year Results
BRIEF published on 04/15/2025 at 17:50, 1 year 2 months ago Des avancées médicales prometteuses vers l'étude SPHINX pour le traitement de l'incontinence urinaire à l'effort (IUE) chez la femme Médical Aisé Appareil Artus Étude SPHINX Incontinence D'effort Féminine Minimalement Invasif
BRIEF published on 04/15/2025 at 17:50, 1 year 2 months ago Affluent Medical Advances Towards SPHINX Study for Female SUI Treatment Affluent Medical Artus Device SPHINX Study Female Stress Incontinence Minimally Invasive
PRESS RELEASE published on 04/15/2025 at 17:45, 1 year 2 months ago Affluent Medical progresse vers une étude clinique européenne sur le sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort chez la femme. Affluent Medical progresse vers une étude clinique européenne sur le sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort chez la femme Affluent Medical Étude Clinique Sphincter Artificiel Artus Incontinence Urinaire D'effort Femme
PRESS RELEASE published on 04/15/2025 at 17:45, 1 year 2 months ago Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women. Affluent Medical progresses towards European clinical study of Artificial Sphincter Artus for treating Urinary Stress Incontinence in Women. The upcoming SPHINX study will assess device safety and performance Affluent Medical Women European Clinical Study Artificial Sphincter Artus Urinary Stress Incontinence
PRESS RELEASE published on 04/15/2025 at 17:45, 1 year 2 months ago Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women Affluent Medical progresses towards European clinical study of Artus artificial sphincter for treating urinary stress incontinence in women. Minimally invasive procedure feasibility confirmed Affluent Medical Women Artus European Clinical Study Urinary Stress Incontinence
BRIEF published on 04/11/2025 at 17:45, 1 year 2 months ago Mise à jour du capital et des droits de vote d'Affluent Medical Euronext Paris Droits De Vote Capital Social AMF Affluent Medical
BRIEF published on 04/11/2025 at 17:45, 1 year 2 months ago Update of Affluent Medical's capital and voting rights Euronext Paris Share Capital Voting Rights AMF Affluent Medical
PRESS RELEASE published on 04/11/2025 at 17:40, 1 year 2 months ago Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25 Affluent Medical communique le nombre d'actions et de droits de vote au 31.03.25, conformément aux dispositions réglementaires françaises Communication Financière Droits De Vote Capital Social Actions Affluent Medical
BRIEF published on 03/11/2025 at 17:50, 1 year 3 months ago Affluent Medical nomme de nouveaux dirigeants pour faire progresser les innovations médicales Innovation Dispositifs Médicaux Essais Cliniques Médical Aisé Nominations À La Direction
Published on 06/29/2026 at 15:00, 4 hours 30 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 4 hours 30 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 14:30, 5 hours ago Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web
Published on 06/29/2026 at 14:30, 5 hours ago US FDA Has Granted A "Rare Pediatric Disease Drug" Designation for NV-387 As A Treatment for Measles - Enables Priority Review Voucher
Published on 06/29/2026 at 19:00, 30 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 22 JUIN 2026 au 26 JUIN 2026
Published on 06/29/2026 at 17:57, 1 hour 33 minutes ago EQS-Adhoc: H&R GmbH & Co. KGaA: Earnings performance significantly exceeding expectations in the second quarter of 2026 – potential target achievement already by mid-year
Published on 06/29/2026 at 17:45, 1 hour 45 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 06/29/2026 at 16:48, 2 hours 42 minutes ago Amprion successfully signs €6.5 billion “Energiewende Green Revolving Credit Facility”
Published on 06/29/2026 at 18:30, 1 hour ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 1 hour ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 1 hour 45 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros